Recent 8-K filings for USNA
Highest-materiality recent filing
USANA preliminary Q3 net loss $6.5M, sales $214M, tax rate spikes to 471%; full-year EPS guidance cut
- Q3 net sales $214M (up from $200M YoY) but operating earnings fall to $1.2M from $15.6M.
- Diluted EPS loss $0.36 ($0.56 profit in Q3 2024); adjusted EPS loss $0.15.
-
USANA Q1 2026 EPS down 16% YoY to $0.41; reaffirms FY guidance
Net sales $250M flat YoY; net earnings $7.5M (-20%); diluted EPS $0.41 vs $0.49.
-
USANA Q4 net loss $1.8M; core customers down 15%; FY2026 guidance flat to 8% growth
Q4 net loss $1.8M vs profit $4.5M YoY; adjusted diluted EPS $0.60 (down 6% from $0.64).
-
USANA sets CEO Guest compensation at $850K base, $1.7M RSU; Brown gets $1.5M severance
Jim Brown transitions to strategic advisor through Dec 31, 2026; receives $825K salary, eligible for 2025 bonus, benefits.
-
USANA prelim FY2025 sales ~$925M (beat guidance); FY2026 guidance $925M-$1B
Preliminary FY2025 net sales of ~$925M, above prior guidance of ~$920M.
-
USANA CEO Jim Brown steps down; Kevin Guest returns as CEO effective immediately
Jim Brown stepped down as CEO and President after 19 years; will remain in advisory role.
-
USANA Q3 net loss of $6.5M; lowers FY25 EPS guidance to $0.78 from $1.50-$2.20
Net sales $214M (+7% YoY) but net loss -$6.5M vs +$10.6M prior year; adj. diluted EPS -$0.15.
-
Q3 net sales $214M (up from $200M YoY) but operating earnings fall to $1.2M from $15.6M.
-
USANA Q2: net sales +11% to $236M, net earnings -7%; FY guidance reiterated
Net sales $236M (+11% YoY); net earnings $9.7M (-7% YoY); diluted EPS $0.52 (-4% YoY).
-
USANA shareholders approve 2025 Equity Incentive Plan at annual meeting
All eight director nominees elected, including Kevin G. Guest and Xia Ding.
-
USANA Q1 net sales up 10% to $250M; EPS down 43% to $0.49; reiterates FY outlook
Net sales $250M (+10% YoY); net earnings $9.4M (-43%); diluted EPS $0.49 vs $0.86.
-
USANA acquired controlling interest in Hiya on Dec 23, 2024; audited financials of Hiya now filed.
-
USANA Q4 net sales -3% to $214M; net earnings -73% to $4.5M; FY2025 guidance includes Hiya
Q4 net sales $214M (-3% YoY); net earnings $4.5M (-73%); diluted EPS $0.23 (-74%).
-
USANA acquires 78.8% stake in Hiya Health for $205M; Hiya had $103M sales, $22M adjusted EBITDA LTM
Acquired 78.8% controlling stake in Hiya Health for $205M cash; closed Dec 23, 2024.
-
USANA Q3 net sales $200M (-6% YoY); cuts FY2024 EPS guidance to $2.45
Q3 diluted EPS $0.56 vs $0.59 YoY; net sales down 6% to $200M.
-
USANA Q2 net sales $213M (-11% YoY), EPS $0.54 (-39%); cuts FY2024 guidance
Diluted EPS $0.54 vs. $0.89 in Q2 2023; net sales $213M down 11% YoY to $238M.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.85 · Median 0.70 · Most common event earnings